LCNB (NASDAQ:LCNB) reported quarterly earnings of $0.39 per share. This is a 18.18 percent increase over earnings of $0.33 per share from the same period last year.
Clarus Therapeutics Announces Comprehensive Settlement of Patent Litigation With Lipocine; Says Agreed To Settle All Outstanding Claims In Patent Infringement Lawsuit
Clarus and Lipocine (NASDAQ:LPCN) agreed to settle all outstanding claims in the patent infringement lawsuit brought against Clarus by Lipocine and to further resolve a patent interference between the parties. The action
